Advos

Advos

Advos.io

@advos

26947 articles
Extend your brand profile by curating daily news.

Articles

ONAR Holding Corporation Taps IBN for Strategic Corporate Communications Expansion

ONAR Holding Corporation Taps IBN for Strategic Corporate Communications Expansion

ONAR Holding Corporation, a global marketing technology firm, has selected Investor Brand Network (IBN) to lead its corporate communications initiatives. The strategic partnership aims to enhance the company's market presence and visibility among investors and industry stakeholders.The collaboration will utilize IBN's expan...
Innovative Microbial Fertilizer Offers Hope for Kenya's Food Security Crisis

Innovative Microbial Fertilizer Offers Hope for Kenya's Food Security Crisis

Easy Environmental Solutions is targeting Kenya's critical food insecurity challenges with an innovative agricultural technology designed to revitalize unproductive farmland. The company's proprietary Terreplenish microbial fertilizer, developed through its Easy FEN Modular Microbe Fertilizer System, offers a potential solu...
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch to Combat Opioid Crisis

Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch to Combat Opioid Crisis

Nutriband Inc. (NASDAQ: NTRB) is addressing the complex challenges of the opioid epidemic through innovative pharmaceutical technology with its development of AVERSA Fentanyl, an abuse-deterrent transdermal patch.The opioid crisis continues to challenge public health systems, requiring nuanced approaches that balance patien...
Oragenics Advances Concussion Treatment with Phase II Trial Approval in Australia

Oragenics Advances Concussion Treatment with Phase II Trial Approval in Australia

Oragenics Inc., a biotechnology company specializing in intranasal therapies, has secured approval from Australia's Human Research Ethics Committee to initiate a Phase II clinical trial for ONP-002, its innovative neuroprotective treatment for mild traumatic brain injury (mTBI).The trial represents a significant milestone i...
Tonix Pharmaceuticals Advances Fibromyalgia Treatment, Reports Q1 Financial Results

Tonix Pharmaceuticals Advances Fibromyalgia Treatment, Reports Q1 Financial Results

Biopharmaceutical company Tonix Pharmaceuticals is preparing for a potentially significant milestone in fibromyalgia treatment with its drug TNX-102 SL, which could become the first new drug class for the condition in more than 15 years. The company is anticipating an FDA decision with a PDUFA goal date of August 15, 2025.F...
IotaComm Launches Investment Campaign to Expand IoT Wireless Network Infrastructure

IotaComm Launches Investment Campaign to Expand IoT Wireless Network Infrastructure

IotaComm, a wireless communications company, is launching a Regulation Crowdfunding investment campaign to accelerate the development of its dedicated Internet of Things (IoT) wireless network. The company's proprietary Delphi360™ platform aims to enable real-time monitoring of critical infrastructure systems across various...
Building Texas Show
G Mining Ventures Corp. to Restate 2024 Financials, Adjusts Net Income by $32 Million

G Mining Ventures Corp. to Restate 2024 Financials, Adjusts Net Income by $32 Million

G Mining Ventures Corp. announced plans to restate its 2024 consolidated financial statements, revealing non-cash accounting adjustments totaling approximately $32 million related to foreign exchange treatments. The restatement will modify the company's financial reporting without affecting its operational capabilities or c...
Intelligent Bio Solutions Sees Revenue Growth and Improved Margins in Q3

Intelligent Bio Solutions Sees Revenue Growth and Improved Margins in Q3

Intelligent Bio Solutions (Nasdaq: INBS) demonstrated financial progress in its fiscal third quarter of 2025, reporting a 20% sequential revenue increase to $728,867. The medical technology company's performance was primarily driven by robust cartridge sales, which now represent 58% of total revenue and are strengthening it...
CNS Pharmaceuticals Secures Orphan Drug Designation for Brain Cancer Treatment TPI 287

CNS Pharmaceuticals Secures Orphan Drug Designation for Brain Cancer Treatment TPI 287

CNS Pharmaceuticals announced the successful transfer of Orphan Drug Designation for TPI 287, a microtubule-stabilizing drug candidate targeting multiple serious neurological conditions. The designation covers gliomas, pediatric neuroblastoma, and progressive supranuclear palsy, signaling potential breakthrough treatments f...
SKYX Platforms Set to Present Q1 2025 Financial Results in Upcoming Investor Call

SKYX Platforms Set to Present Q1 2025 Financial Results in Upcoming Investor Call

SKYX Platforms Corp. (NASDAQ: SKYX) will hold a corporate update call on Wednesday, May 14, at 4:30 p.m. ET to discuss its first quarter 2025 financial results. The call will feature key leadership, including Founder and Executive Chairman Rani Kohen, President Steve Schmidt, Co-CEO Lenny Sokolow, and CFO Marc Boisseau.The ...
Brera Holdings Advances Sustainable Football Investment Strategy with Multi-Club Ownership Approach

Brera Holdings Advances Sustainable Football Investment Strategy with Multi-Club Ownership Approach

Brera Holdings PLC (NASDAQ: BREA), an Ireland-based international holding company, continues to refine its strategy for global sports club investment through a multi-club ownership (MCO) model that prioritizes sustainable growth and local market understanding.The company's approach diverges from traditional trophy asset acq...
U.S. Clean Energy Sector Thrives, But Political Headwinds Pose Challenges

U.S. Clean Energy Sector Thrives, But Political Headwinds Pose Challenges

The United States has experienced a significant surge in renewable energy production over the past decade, with total clean energy output tripling during this period. However, the sector now confronts considerable challenges stemming from the Trump administration's policy approach and substantial budget reductions.Despite t...
Building Texas Show
Mazda Shifts to Tesla's NACS Charging Standard in Japan

Mazda Shifts to Tesla's NACS Charging Standard in Japan

Mazda will transition its electric vehicles in Japan to use the North American Charging Standard (NACS), originally developed by Tesla, beginning in 2027. The automotive manufacturer's decision represents a significant step in standardizing electric vehicle charging technology in the Japanese market.By adopting NACS, Mazda ...
Senate Democrats Block Crypto Regulatory Bill, Signaling Shifting Political Landscape

Senate Democrats Block Crypto Regulatory Bill, Signaling Shifting Political Landscape

Senate Democrats have unexpectedly blocked a cryptocurrency regulatory measure that previously enjoyed strong industry support, marking a significant setback for digital currency legislation during Donald Trump's second presidential term. The move signals a potential shift in Washington's approach to cryptocurrency regulati...
TGI Fridays Revamps Menu with Bold Flavors and Signature Cocktails

TGI Fridays Revamps Menu with Bold Flavors and Signature Cocktails

TGI Fridays is transforming its dining experience with a bold new menu that promises to reinvigorate the casual dining segment. Led by CEO Ray Blanchette, the restaurant chain is leveraging its heritage of flavor innovation to attract both loyal customers and new diners.The menu's centerpiece is a reimagined mozzarella stic...
UNFTR Launches Progressive '5 Non-Negotiables' Campaign to Reshape Political Dialogue

UNFTR Launches Progressive '5 Non-Negotiables' Campaign to Reshape Political Dialogue

The progressive media platform UNFTR has unveiled a comprehensive political campaign called the '5 Non-Negotiables', targeting fundamental systemic challenges facing American society. The initiative seeks to advance a bold progressive agenda that addresses critical issues including housing, labor, healthcare, election integ...
Mobilicom to Showcase Cybersecure Drone Solutions at Ladenburg Thalmann Innovation EXPO25

Mobilicom to Showcase Cybersecure Drone Solutions at Ladenburg Thalmann Innovation EXPO25

Mobilicom Limited, a provider of cybersecurity solutions for drones and robotics, will present its technological innovations at the Ladenburg Thalmann Innovation EXPO25 on May 21, 2025, in New York City. The event presents a critical opportunity for the company to demonstrate its growing market presence and technological ad...
Players Health and MaxU Partner to Advance Mental Resilience in Youth Sports

Players Health and MaxU Partner to Advance Mental Resilience in Youth Sports

Players Health, a sports technology company, and MaxU have announced a strategic partnership aimed at enhancing mental performance and resilience among youth athletes across North America. The collaboration seeks to integrate advanced mental skills training into the athletic development ecosystem.The partnership responds to...
InVitro International Reports Growth in Non-Animal Testing Technologies

InVitro International Reports Growth in Non-Animal Testing Technologies

InVitro International (OTCQB: IVRO) reported first half fiscal year 2025 financial results, highlighting modest sales growth and ongoing efforts to advance non-animal testing technologies. The company recorded sales of $440,650, representing a 4.4% increase compared to the same period in the previous fiscal year.Despite the...
Stocktwits Sponsors Ladenburg Thalmann Innovation EXPO25, Highlighting AI Technology Showcase

Stocktwits Sponsors Ladenburg Thalmann Innovation EXPO25, Highlighting AI Technology Showcase

Stocktwits, a leading social media platform for investors and traders, has been confirmed as a sponsor for the Ladenburg Thalmann Innovation EXPO25, a significant one-day conference focused on technological innovation and investment opportunities.The event, scheduled for May 21, 2025, at Convene in New York City, will featu...
SeaStar Medical Achieves Rare Six FDA Breakthrough Device Designations

SeaStar Medical Achieves Rare Six FDA Breakthrough Device Designations

Medical device company SeaStar Medical has achieved a significant milestone by obtaining six FDA Breakthrough Device Designations (BDD) between April 2022 and March 2025. The company's Selective Cytopheretic Device (SCD) therapy aims to treat complex medical conditions with limited existing treatment options, potentially im...

Showing 18082-18102 of 26947 articles (Page 862 of 1284)